Shilpa Medicare declares ₹0.60 dividend, adopts FY26 financials
- Shilpa Medicare declared a dividend of ₹0.60 per equity share for FY26
- Shareholders adopted audited standalone and consolidated financial statements
- Mr. Sharath Reddy Kalakota was re-appointed as Director after retiring by rotation
- Commission payment to a director of material subsidiary Shilpa Biologicals was approved
- The 39th AGM was held via VC/OAVM with 48 members participating remotely
*this image is generated using AI for illustrative purposes only.
Shilpa Medicare declared a dividend of ₹0.60 per equity share for the financial year ended March 31, 2026, during its 39th Annual General Meeting held on September 11, 2026.
The meeting, conducted via Video Conferencing and Other Audio-Visual Means from the company’s registered office, saw shareholders adopt the audited standalone and consolidated financial statements for FY26. The statutory and secretarial auditor reports were unqualified, with no adverse observations noted.
Key Resolutions Passed
Shareholders approved several ordinary resolutions during the proceedings:
| Resolution Description | Type |
|---|---|
| Adoption of audited standalone and consolidated financial statements for FY26 | Ordinary |
| Declaration of ₹0.60 per equity share dividend for FY26 | Ordinary |
| Re-appointment of Mr. Sharath Reddy Kalakota as Director | Ordinary |
| Ratification of remuneration of Cost Auditors | Ordinary |
| Payment of commission to Mr. Madhav Vishnukant Bhutada | Ordinary |
Mr. Sharath Reddy Kalakota (DIN: 03603460), who retired by rotation, offered himself for re-appointment and was subsequently appointed. The board also approved the payment of commission to Mr. Madhav Vishnukant Bhutada (DIN: 08222055), a Non-Executive Director of Shilpa Biologicals Private Limited, a material subsidiary of the company.
Meeting Proceedings
Mr. Omprakash Inani, Chairman, chaired the meeting, which commenced at 11:00 am and concluded at 11:57 am. Ms. Ritu Tiwary, Company Secretary and Compliance Officer, confirmed the presence of the requisite quorum, including key managerial personnel, auditors, and committee chairpersons.
The total number of shareholders as on the record date of September 4, 2026, was 80,572. Of these, 48 members participated through the video conference platform. The Chairman and Managing Director addressed members on the company’s performance and future outlook.
An insta-poll was conducted for 15 minutes following the conclusion of the AGM to allow members who had not voted via remote e-voting to cast their ballots. The combined results of e-voting and insta-poll, along with the Scrutinizer’s Report, will be declared to stock exchanges within the regulatory timeline.
Historical Stock Returns for Shilpa Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.26% | +0.52% | +19.02% | +183.82% | +130.27% | 0.0% |
How does the ₹0.60 per share dividend compare to Shilpa Medicare's payout history, and what does this signal about management's confidence in future cash flows?
What specific growth initiatives or R&D pipelines did the Chairman highlight during his address on the company's future outlook?
How might the re-appointment of Mr. Sharath Reddy Kalakota influence the company's strategic direction and governance stability in the coming fiscal year?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
